Mar 8 |
Lineage Cell Therapeutics, Inc. (LCTX) Q4 2023 Earnings Call Transcript
|
Mar 7 |
Lineage Cell Therapeutics GAAP EPS of -$0.03 in-line, revenue of $2.1M misses by $0.74M
|
Mar 7 |
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Mar 7 |
Earnings Scheduled For March 7, 2024
|
Mar 6 |
Lineage Cell Therapeutics Q4 2023 Earnings Preview
|
Feb 29 |
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
|
Feb 9 |
Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering
|
Feb 6 |
Lineage Cell Therapeutics looks to raise $14M through direct offering
|
Feb 6 |
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
|
Jan 3 |
Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying
|